RIP
AMGN icon

Reliant Investment Partners’s Amgen AMGN Stock Holding History

Reliant Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
609
+10
+2% +$3.42K 0.15% 117
2026
Q1 		$211K Buy
+599
New +$214K 0.17% 106

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Reliant Investment Partners's AMGN Position: Q2 2026 in Review

Reliant Investment Partners increased its Amgen (AMGN) stake by 1.7% in Q2 2026, buying an estimated $3.42K and bringing the position to 609 shares worth $221K. The position accounts for 0.15% of the portfolio, ranked #117.

Reliant Investment Partners first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Reliant Investment Partners held 609 shares of Amgen worth $221K as of Q2 2026.
  • Reliant Investment Partners bought 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up 0.15% of Reliant Investment Partners's portfolio in Q2 2026, its #117 holding.
  • Reliant Investment Partners first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.